PollNowData
Back to companies

Cellivery Therapeutics, Inc.

268600KRKRX

셀리버리

Revenue
₩18.9bn
FY2023
Operating income
-₩19.6bn
FY2023
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)